TB Modeling and Analysis Consortium

Location

Baltimore, Maryland, US

Dates

01/01/2013 - 12/01/2015

PI

David Dowdy, MD, PhD, ScM

The TB MAC brings TB modelers together from a wide range of institutions to answer questions of global policy relevance.  I sit on the 7-member steering committee, and we have contributed modeling results to a recent comparative modeling exercise aiming to understand our capacity to reach the post-2015 TB targets.

Projects

A randomized trial of preventive therapy for...

We are evaluating the efficacy and cost-effectiveness of levofloxacin preventive therapy for pediatric contacts of MDR TB...

Read More

A Blueprint for Success: Understanding the...

We are using a combination of statistical analysis and transmission modeling, in collaboration with the NYC Dept of Health &...

Read More

MDR TB treatment as prevention: modeling the...

We are using transmission modeling to evaluate the potential impact of expanding DST and access to MDR TB treatment in Vietnam,...

Read More

ACTG trial A5343

Phase 2 safety study of bedaquiline and delamanid for the treatment of MDR-TB in South Africa

Read More